A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis

Neurology

Volumn 61, Issue 11, 2003, Pages 1503-1507

  Sorenson, Eric J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CALCULATION; CLINICAL TRIAL; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MANUAL MUSCLE TESTING; MAXIMAL VOLUNTARY ISOMETRIC CONTRACTION TEST; MEDICAL RESEARCH COUNCIL SCALE; MULTICENTER STUDY; MUSCLE STRENGTH; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; REPRODUCIBILITY; SCORING SYSTEM; TIME; UNITED STATES; VALIDATION PROCESS;

EID: 0345043998     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000095961.66830.03     Document Type: Article

References (14)

1. Miller RG, Munsat TL, Swash M, Brooks BR. Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology Committee on Research. J Neurol Sci 1999;169:2-12.
2. Aitkens S, Lord J, Bernauer E, Fowler WM Jr, Lieberman JS, Berck P. Relationship of manual muscle testing to objective strength measurements. Muscle Nerve 1989;12:173-177.
3. Andersen H, Jakobsen J. A comparative study of isokinetic dynamometry and manual muscle testing of ankle dorsal and plantar flexors and knee extensors and flexors. Eur Neurol 1997;37:239-242.
4. Hoagland RJ, Mendoza M, Armon C, et al. Reliability of maximal voluntary isometric contraction testing in a multicenter study of patients with amyotrophic lateral sclerosis. Syntex/Synergen Neuroscience Joint Venture rhCNTF ALS Study Group. Muscle Nerve 1997;20:691-695.
5. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124 suppl:96-107.
6. Brooke MH, Fenichel GM, Griggs RC, et al. Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 1983;6:91-103.
7. Medical Research Council. Aids to the examination of the peripheral nervous system. London: Her Majesty's Stationery Office, 1976;14.
8. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology 1986;36:937-941.
9. Andres PL, Finison LJ, Conlon T, Thibodeau LM, Munsat TL. Use of composite scores (megascores) to measure deficit in amyotrophic lateral sclerosis. Neurology 1988;38:405-408.
10. The National Isometric Muscle Strength (NIMS) Database Consortium. Muscular weakness assessment: use of normal isometric strength data. Arch Phys Med Rehabil 1996;77:1251-1255.
11. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. The Amyotrophic Lateral Sclerosis Functional Rating Scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996;53:141-147.
12. Cedarbaum JM, Stambler N, Malta E, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13-21.
13. Dyck PJ, Kratz KM, Lehman KA, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799-807.
14. Hemmerle WJ, Hartley HO. Computing maximum likelihood estimates for the mixed A.O.V. model using the W Transformation. Technometrics 1973;15:819-831.